Cooper Companies Inc (COO)
The Cooper Companies, Inc. is a healthcare company whose common stock is listed on NASDAQ under the ticker COO. Through its subsidiaries, the company develops, manufactures, and markets products for contact lens wearers and for family and women’s health care. Its CooperVision segment supplies spherical, toric, and multifocal contact lenses designed to address conditions including astigmatism, presbyopia, and myopia. The CooperSurgical segment provides fertility products and services, medical devices, contraception, cryostorage solutions such as cord blood and cord tissue storage, and other reproductive health offerings. This segment also includes Paragard, a hormone-free intrauterine device, along with fertility consumables and equipment, donor gamete services, and genomic testing services. Cooper sells through distributors, group purchasing organizations, eye care and healthcare professionals, and authorized resellers. The company was founded in 1958 and is headquartered in San Ramon, California.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-COO
|
$82.58
|
15.7% Upside
|
Fair
|
$81.69
|
14.5% Upside
|
Fair
|
Good
|
—
|
—
|
—
|
0.0%
|
September 2, 2026
|
59.1x
|
1.7x
|
3.3x
|
13.962 B
|
16.525 B
|
16.4%
|
99.3%
|
4.4
|
—
|
241.5%
|
